Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting.

Trial Profile

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
  • Indications Human papillomavirus infections; Penile cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Jun 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
    • 27 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2011 Planned end date changed from 1 Jan 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top